Cornerstone Advisors (Washington)’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | $17K | Hold |
76
| – | – | ﹤0.01% | 386 |
|
2020
Q2 | $13K | Sell |
76
-15
| -16% | -$2.57K | ﹤0.01% | 410 |
|
2020
Q1 | $11K | Buy |
91
+20
| +28% | +$2.42K | ﹤0.01% | 405 |
|
2019
Q4 | $11K | Sell |
71
-8
| -10% | -$1.24K | ﹤0.01% | 404 |
|
2019
Q3 | $10K | Buy |
79
+26
| +49% | +$3.29K | ﹤0.01% | 411 |
|
2019
Q2 | $8K | Buy |
53
+37
| +231% | +$5.59K | ﹤0.01% | 832 |
|
2019
Q1 | $2K | Buy |
16
+6
| +60% | +$750 | ﹤0.01% | 987 |
|
2018
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 955 |
|
2018
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 973 |
|
2018
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 950 |
|
2018
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 933 |
|
2014
Q3 | – | Sell |
-10
| Closed | -$1K | – | 603 |
|
2014
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 554 |
|
2014
Q1 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 462 |
|